Guardant Health
GH
#2739
Rank
C$6.97 B
Marketcap
$56.49
Share price
-2.12%
Change (1 day)
119.91%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2024 (TTM): -C$0.6 Billion

According to Guardant Health 's latest financial reports the company's current earnings are C$0.73 Billion. , an increase over its 2023 earnings that were of -C$0.69 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2024

Annual earnings

Year Earnings Change
2024 -C$0.63 Billion-9.12%
2023 -C$0.69 Billion-26.73%
2022 -C$0.94 Billion69.96%
2021 -C$0.56 Billion56.35%
2020 -C$0.36 Billion252.69%
2019 -C$0.11 Billion-17.22%
2018 -C$0.13 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.31 Billion-51.17%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.73 Billion 15.93%๐Ÿ‡บ๐Ÿ‡ธ USA